Why Insurers Are Vital to the Future of Digital Therapeutics

Our latest research predicts that adoption of digital therapeutics is set to skyrocket over the next four years, as consumers and industry stakeholders recognise their value to the delivery of proactive healthcare. However, adoption is still low among private insurers.

So we ask: How vital are private insurers to the future of the digital therapeutics market? And what strategies can vendors use to make their offerings more attractive to private insurers?

Download the whitepaper: How Digital Therapeutics Are Redefining Chronic Care in 2022

Related Research: Digital Therapeutics & Wellness: Market Forecasts, Key Trends & Business Models 2022-2026